Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety Scrutiny

benzinga.com/government/regulations/25/05/45488265/novavax-wins-limited-fda-nod-for-covid-shot-cleared-only-for-seniors-high-risk-groups-amid

The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.’s (NASDAQ:NVAX) COVID-19 vaccine, restricting its use to people 65 and older and those 12 and up with underlying health conditions that increase the risk of severe illness.
What Happened: The decision…

This story appeared on benzinga.com, 2025-05-19 08:39:34.
The Entire Business World on a Single Page. Free to Use →